2010
DOI: 10.1021/ja106288c
|View full text |Cite
|
Sign up to set email alerts
|

Dual Functional Polyelectrolyte Multilayer Coatings for Implants: Permanent Microbicidal Base with Controlled Release of Therapeutic Agents

Abstract: Here we present a new bifunctional layer-by-layer (LbL) construct made by combining a permanent microbicidal polyelectrolyte multilayered (PEM) base film with a hydrolytically degradable PEM top film that offers controlled and localized delivery of therapeutics. Two degradable film architectures are presented: 1) bolus release of an antibiotic (gentamicin) to eradicate initial infection at the implant site, or 2) sustained delivery of an anti-inflammatory drug (diclofenac) to cope with inflammation at the site… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
77
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(79 citation statements)
references
References 42 publications
(119 reference statements)
1
77
0
Order By: Relevance
“…Numerous drug delivery systems (DDS) of antibiotic are presented in the literature [48][49][50]. The ideal DDS for the bacterial infection is described as having the following characteristics [51]: it must have a wide spectrum activity (efficient against the most common bacterial pathogens involved in chronic osteomyelitis); it must be locally released; it must be unable to enter in the systemic circulation; it must be stable at the body temperature; it must not produce supra infection.…”
Section: Gs Release and In Vitro Activitymentioning
confidence: 99%
“…Numerous drug delivery systems (DDS) of antibiotic are presented in the literature [48][49][50]. The ideal DDS for the bacterial infection is described as having the following characteristics [51]: it must have a wide spectrum activity (efficient against the most common bacterial pathogens involved in chronic osteomyelitis); it must be locally released; it must be unable to enter in the systemic circulation; it must be stable at the body temperature; it must not produce supra infection.…”
Section: Gs Release and In Vitro Activitymentioning
confidence: 99%
“…Therefore, new multifunctional coatings are being explored that combine releasekilling and contact-killing capabilities. 23,24 Moreover, antibacterial surfaces have been designed that can respond to light or pH. 25,26 The present study goes beyond this prior work by describing a new type of coating that was engineered to combine permanent, contactkilling protection with bacteria-triggered, on-demand release of antimicrobials.…”
Section: Introductionmentioning
confidence: 99%
“…18 Although these releasable therapies are potent antimicrobials, resistance concerns plaque their wide-spread use. 46, 47 The QA-functionalized particles described herein were designed to allow for the release of NO, a broad-spectrum antimicrobial with low risk of resistance.…”
Section: Resultsmentioning
confidence: 99%
“…7, 17 Similarly, Wong et al reported improved efficacy of QA-functionalized layer-by-layer coatings that leached gentamicin against biofilm formation. 18 …”
Section: Introductionmentioning
confidence: 99%